In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Acelity announces $400mm senior notes offering

Executive Summary

Acelity LP Inc.'s advanced wound care subsidiaries Kinetic Concepts Inc. and KCI USA Inc. offered $400mm principal amount of first lien senior secured notes due 2021 through a private transaction to qualified institutional investors. The notes mature on February 15, 2021, and accrue interest at a rate of 7.875% per year. Proceeds will help repay Acelity's existing senior term credit facility (due November 4, 2016), and will also be used for general corporate purposes.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Rehabilitation Equipment and Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Nonconvertible Debt
    • Private Placement

Related Companies